Medicaid ends funding for child sex-change procedures as Trump admin slams 'experimental' treatments

The Centers for Medicare and Medicaid Services, headed by Mehmet Oz, announced that Medicaid and CHIP will no longer cover puberty blockers, cross-sex hormones, or sex change surgeries for children. CMS cited concerns about evidence and safety in the announcement. The decision affects coverage across all state Medicaid programs and the Children's Health Insurance Program.

Next story